Our topic is "Transantral Decompression for Malignant Exophthalmos." As the title indicates, this is another example in the ever-widening field of otolaryngology. If the welfare of the patient is served, diversification is permissible. It is our firm belief that the otolaryngologist can offer substantial aid to the patient suffering from malignant exophthalmos.
Despite tremendous advances in diagnostic methods and therapeutic procedures available for the management of Graves' disease, exophthalmos remains its most baffling and least understood component. Differentiation into thyrotoxic and thyrotropic (malignant) exophthalmos serves a useful purpose from the clinical standpoint.
Thyrotoxic exophthalmos is a relatively mild involvement characterized by a slight "compressible" type of ocular protrusion, lid retraction, and possibly some thinning of the extraocular muscles. Except for the undesirable cosmetic effect the condition is harmless and the prognosis favorable.
Our discussion deals with thyrotropic exophthalmos (also described as malignant, progressive, or endocrine exophthalmos, hyperophthalmos of Graves' disease,
JAMES S. WALKER, G. LeROY PORTER. Transantral Decompression for Malignant Exophthalmos. AMA Arch Otolaryngol. 1958;68(2):152–155. doi:10.1001/archotol.1958.00730020158004